Basic Information
| LncRNA/CircRNA Name | p34822 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR |
| Sample | hepatocellular carcinoma tissues, cell lines (HepG2, Huh7, SMMC-7721, Hep3B, LO2) |
| Expression Pattern | up-regulated |
| Function Description | we found that plasma lncRNA p34822 is dramatically up-regulated in HCC patients.we found that circulating lncRNAs are remarkably stable at room temperature, |
| Pubmed ID | 28547580 |
| Year | 2017 |
| Title | Identification of long non-coding RNA p34822 as a potential plasma biomarker for the diagnosis of hepatocellular carcinoma. |
External Links
| Links for p34822 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |